Mjali A, Obaid MM, Matti BF, Abbas NT. Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq. Asian Pac J Cancer Care [Internet]. 2022 Jun. 14 [cited 2026 May 29];7(2):267-72. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/870